Paul Jai Sekhri is an American businessperson who founded Cerimon Pharmaceuticals, Inc. and who has been at the helm of 10 different companies. Currently, Mr. Sekhri holds the position of Chairman at Compugen Ltd., Chairman for Pharming Group NV, President, Chief Executive Officer & Director at eGenesis, Inc., Venture Partner at Medicxi Ventures (Jersey) Ltd. and Chairman at Pharming NV.
He is also Member of Ontario Institute for Cancer Research and Managing Director & Operating Partner at Tarrant Capital IP LLC and on the board of 17 other companies.
In the past he occupied the position of Chairman for moksha8 Pharmaceuticals, Inc., Chairman for Topas Therapeutics GmbH, President & Chief Executive Officer of Cerimon Pharmaceuticals, Inc., President, Chief Executive Officer & Director at Lycera Corp., Chief Strategy Officer & EVP-Business Development at Teva Pharmaceutical Industries Ltd., Venture Partner at MPM Capital Inc, Partner-Healthcare Investments at New Leaf Venture Partners LLC, Member-Patrons Council at The Carnegie Hall Society, Inc., President & Chief Business Officer at ARIAD Pharmaceuticals, Inc., Partner at Sprout Group, Senior Vice President-Integrated Care at Sanofi, Inc., Operating Partner & Head-Biotechnology Operations at TPG Biotech Equity LP, Senior VP, Head-Global Search & Evaluation at Novartis Pharma AG, Senior Vice President-Integrated Care at Sanofi SA and Operating Partner at Highline Therapeutics, Inc.
He received an undergraduate degree from the University of Maryland and a graduate degree from the University of Maryland School of Medicine.